Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials |
| |
| Authors: | S G Nayfield P A Ganz C M Moinpour D F Cella B J Hailey |
| |
| Institution: | (1) Community Oncology and Rehabilitation Branch, Division of Cancer Prevention and Control, National Cancer Institute, Executive Plaza North, Room 300, 20892 Bethesda, MD, USA;(2) UCLA-San Fernando Valley Program, Veterans Affairs Medical Center, Sepulveda, CA, USA;(3) Fred Hutchinson Cancer Research Center, Seattle, WA, USA;(4) Rush-Presbyterian-St Luke's Medical Center, Chicago, IL, USA;(5) University of Southern Mississippi, Hattiesburg, MS, USA |
| |
| Abstract: | To promote the inclusion of quality of life (QOL) end-points in clinical research on cancer, the National Cancer Institute (USA) sponsored a workshop on QOL assessment in cancer clinical trials in July, 1990. Experts in clinical trials and QOL research formed four working groups to identify current areas of cancer treatment in which QOL end-points are most important; to discuss methodologic problems in QOL assessment; to address common problems in implementing clinical studies with QOL end-points; and to consider statistical issues in design, implementation, and data analysis. Recommendations made by the working groups are summarized in this paper.This article summarizes recommendations from the four working groups that comprised the workshop. Copies of the full reports are available from Dr Nayfield at the address above. |
| |
| Keywords: | Assessment methods cancer clinical trials quality of life |
| 本文献已被 SpringerLink 等数据库收录！ |
|
